Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02FZW
|
||||
| Former ID |
DNC006774
|
||||
| Drug Name |
17-methyl-4'-methyldihydromorphinone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528375] | ||
| Formula |
C27H28N2O4
|
||||
| Canonical SMILES |
CC1=CC=C(C=C1)C=CC(=O)NC23CCC(=O)C4C25CCN(C3CC6=C5C(=C(<br />C=C6)O)O4)C
|
||||
| InChI |
1S/C27H28N2O4/c1-16-3-5-17(6-4-16)7-10-22(32)28-27-12-11-20(31)25-26(27)13-14-29(2)21(27)15-18-8-9-19(30)24(33-25)23(18)26/h3-10,21,25,30H,11-15H2,1-2H3,(H,28,32)/b10-7+/t21-,25+,26+,27-/m1/s1
|
||||
| InChIKey |
JRFZMFGBYRTYRZ-MDZANWBPSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528375] | |
| Kappa-type opioid receptor | Target Info | Inhibitor | [528375] | ||
| Delta-type opioid receptor | Target Info | Inhibitor | [528375] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||